People: Concert Pharmaceuticals Inc (CNCE.OQ)
25 Apr 2019
Dr. Roger Tung is the Co-Founder, President, Director and CEO of Concert Pharmaceuticals Inc. Before thisBefore Concert, Dr. Tung was a founding scientist at Vertex, a pharmaceutical company, where he was employed from 1989 to 2005, most recently as its Vice President of Drug Discovery. Prior to Vertex, he held various positions at Merck, Sharp & Dohme Research Laboratories, a global healthcare provider, and The Squibb Institute for Medicinal Chemistry. Dr. Tung received a B.A. in Chemistry from Reed College and a Ph.D. in Medicinal Chemistry at the University of Wisconsin-Madison. We believe that Dr. Tung’s detailed knowledge of our company and his 28 year career in the global pharmaceutical and biotechnology industries, including his roles at Vertex, provide a critical contribution to our board of directors.
|Total Annual Compensation, USD||517,402|
|Restricted Stock Award, USD||1,109,600|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||1,803,850|
|Fiscal Year Total, USD||3,430,850|